Detailed TOC of Global GLP-1 Drug Market Growth 2026-2035
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global GLP-1 Drug Annual Sales 2020-2035
2.1.2 World Current & Future Analysis for GLP-1 Drug by Geographic Region, 2020, 2026 & 2035
2.1.3 World Current & Future Analysis for GLP-1 Drug by Country/Region, 2020, 2026 & 2035
2.2 GLP-1 Drug Segment by Type
2.2.1 Short-acting GLP-1 Drug
2.2.2 Long-acting GLP-1 Drug
2.3 GLP-1 Drug Sales by Type
2.3.1 Global GLP-1 Drug Sales Market Share by Type (2020-2026)
2.3.2 Global GLP-1 Drug Revenue and Market Share by Type (2020-2026)
2.3.3 Global GLP-1 Drug Sale Price by Type (2020-2026)
2.4 GLP-1 Drug Segment by Application
2.4.1 Obesity
2.4.2 Type 2 Diabetes (T2DM)
2.4.3 Cardiovascular and Cerebrovascular Diseases (CVD)
2.4.4 Non-alcoholic Steatohepatitis (NASH)
2.4.5 Alzheimer's Disease (AD)
2.5 GLP-1 Drug Sales by Application
2.5.1 Global GLP-1 Drug Sale Market Share by Application (2020-2026)
2.5.2 Global GLP-1 Drug Revenue and Market Share by Application (2020-2026)
2.5.3 Global GLP-1 Drug Sale Price by Application (2020-2026)
3 Global by Company
3.1 Global GLP-1 Drug Breakdown Data by Company
3.1.1 Global GLP-1 Drug Annual Sales by Company (2020-2026)
3.1.2 Global GLP-1 Drug Sales Market Share by Company (2020-2026)
3.2 Global GLP-1 Drug Annual Revenue by Company (2020-2026)
3.2.1 Global GLP-1 Drug Revenue by Company (2020-2026)
3.2.2 Global GLP-1 Drug Revenue Market Share by Company (2020-2026)
3.3 Global GLP-1 Drug Sale Price by Company
3.4 Key Manufacturers GLP-1 Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Drug Product Location Distribution
3.4.2 Players GLP-1 Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for GLP-1 Drug by Geographic Region
4.1 World Historic GLP-1 Drug Market Size by Geographic Region (2020-2026)
4.1.1 Global GLP-1 Drug Annual Sales by Geographic Region (2020-2026)
4.1.2 Global GLP-1 Drug Annual Revenue by Geographic Region (2020-2026)
4.2 World Historic GLP-1 Drug Market Size by Country/Region (2020-2026)
4.2.1 Global GLP-1 Drug Annual Sales by Country/Region (2020-2026)
4.2.2 Global GLP-1 Drug Annual Revenue by Country/Region (2020-2026)
4.3 Americas GLP-1 Drug Sales Growth
4.4 APAC GLP-1 Drug Sales Growth
4.5 Europe GLP-1 Drug Sales Growth
4.6 Middle East & Africa GLP-1 Drug Sales Growth
5 Americas
5.1 Americas GLP-1 Drug Sales by Country
5.1.1 Americas GLP-1 Drug Sales by Country (2020-2026)
5.1.2 Americas GLP-1 Drug Revenue by Country (2020-2026)
5.2 Americas GLP-1 Drug Sales by Type (2020-2026)
5.3 Americas GLP-1 Drug Sales by Application (2020-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Drug Sales by Region
6.1.1 APAC GLP-1 Drug Sales by Region (2020-2026)
6.1.2 APAC GLP-1 Drug Revenue by Region (2020-2026)
6.2 APAC GLP-1 Drug Sales by Type (2020-2026)
6.3 APAC GLP-1 Drug Sales by Application (2020-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe GLP-1 Drug by Country
7.1.1 Europe GLP-1 Drug Sales by Country (2020-2026)
7.1.2 Europe GLP-1 Drug Revenue by Country (2020-2026)
7.2 Europe GLP-1 Drug Sales by Type (2020-2026)
7.3 Europe GLP-1 Drug Sales by Application (2020-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa GLP-1 Drug by Country
8.1.1 Middle East & Africa GLP-1 Drug Sales by Country (2020-2026)
8.1.2 Middle East & Africa GLP-1 Drug Revenue by Country (2020-2026)
8.2 Middle East & Africa GLP-1 Drug Sales by Type (2020-2026)
8.3 Middle East & Africa GLP-1 Drug Sales by Application (2020-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Drug
10.3 Manufacturing Process Analysis of GLP-1 Drug
10.4 Industry Chain Structure of GLP-1 Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Drug Distributors
11.3 GLP-1 Drug Customer
12 World Forecast Review for GLP-1 Drug by Geographic Region
12.1 Global GLP-1 Drug Market Size Forecast by Region
12.1.1 Global GLP-1 Drug Forecast by Region (2026-2035)
12.1.2 Global GLP-1 Drug Annual Revenue Forecast by Region (2026-2035)
12.2 Americas Forecast by Country (2026-2035)
12.3 APAC Forecast by Region (2026-2035)
12.4 Europe Forecast by Country (2026-2035)
12.5 Middle East & Africa Forecast by Country (2026-2035)
12.6 Global GLP-1 Drug Forecast by Type (2026-2035)
12.7 Global GLP-1 Drug Forecast by Application (2026-2035)
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 Drug Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly GLP-1 Drug Product Portfolios and Specifications
13.2.3 Eli Lilly GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca GLP-1 Drug Product Portfolios and Specifications
13.3.3 AstraZeneca GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi GLP-1 Drug Product Portfolios and Specifications
13.4.3 Sanofi GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Pfizer Inc
13.5.1 Pfizer Inc Company Information
13.5.2 Pfizer Inc GLP-1 Drug Product Portfolios and Specifications
13.5.3 Pfizer Inc GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.5.4 Pfizer Inc Main Business Overview
13.5.5 Pfizer Inc Latest Developments
13.6 Hanmi Pharmaceutical Co
13.6.1 Hanmi Pharmaceutical Co Company Information
13.6.2 Hanmi Pharmaceutical Co GLP-1 Drug Product Portfolios and Specifications
13.6.3 Hanmi Pharmaceutical Co GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.6.4 Hanmi Pharmaceutical Co Main Business Overview
13.6.5 Hanmi Pharmaceutical Co Latest Developments
13.7 Teva Pharmaceutical Industries Ltd
13.7.1 Teva Pharmaceutical Industries Ltd Company Information
13.7.2 Teva Pharmaceutical Industries Ltd GLP-1 Drug Product Portfolios and Specifications
13.7.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.7.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Information
13.8.2 Boehringer Ingelheim GLP-1 Drug Product Portfolios and Specifications
13.8.3 Boehringer Ingelheim GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.8.4 Boehringer Ingelheim Main Business Overview
13.8.5 Boehringer Ingelheim Latest Developments
13.9 GlaxoSmithKline (GSK)
13.9.1 GlaxoSmithKline (GSK) Company Information
13.9.2 GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolios and Specifications
13.9.3 GlaxoSmithKline (GSK) GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.9.4 GlaxoSmithKline (GSK) Main Business Overview
13.9.5 GlaxoSmithKline (GSK) Latest Developments
13.10 Huadong Medicine
13.10.1 Huadong Medicine Company Information
13.10.2 Huadong Medicine GLP-1 Drug Product Portfolios and Specifications
13.10.3 Huadong Medicine GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.10.4 Huadong Medicine Main Business Overview
13.10.5 Huadong Medicine Latest Developments
13.11 Gan & Lee Pharmaceuticals
13.11.1 Gan & Lee Pharmaceuticals Company Information
13.11.2 Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolios and Specifications
13.11.3 Gan & Lee Pharmaceuticals GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.11.4 Gan & Lee Pharmaceuticals Main Business Overview
13.11.5 Gan & Lee Pharmaceuticals Latest Developments
13.12 Tonghua Dongbao
13.12.1 Tonghua Dongbao Company Information
13.12.2 Tonghua Dongbao GLP-1 Drug Product Portfolios and Specifications
13.12.3 Tonghua Dongbao GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.12.4 Tonghua Dongbao Main Business Overview
13.12.5 Tonghua Dongbao Latest Developments
13.13 Shanghai Benemae Pharmaceutical Corporation
13.13.1 Shanghai Benemae Pharmaceutical Corporation Company Information
13.13.2 Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Product Portfolios and Specifications
13.13.3 Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.13.4 Shanghai Benemae Pharmaceutical Corporation Main Business Overview
13.13.5 Shanghai Benemae Pharmaceutical Corporation Latest Developments
13.14 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
13.14.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
13.14.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
13.14.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.14.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business Overview
13.14.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
13.15 PegBio Co., Ltd
13.15.1 PegBio Co., Ltd Company Information
13.15.2 PegBio Co., Ltd GLP-1 Drug Product Portfolios and Specifications
13.15.3 PegBio Co., Ltd GLP-1 Drug Sales, Revenue, Price and Gross Margin (2020-2026)
13.15.4 PegBio Co., Ltd Main Business Overview
13.15.5 PegBio Co., Ltd Latest Developments
14 Research Findings and Conclusion
